2023-12-07 11:42:36 ET
Adjusted earnings per share of $2.70–$2.80 are expected in 2024. The consensus estimate is $2.80.
Shares of the company are down 1.6% at $68.36.
More on Edwards Lifesciences
- Edwards Lifesciences Q3: Clinical Trial Updates Impress
- Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
- Edwards Lifesciences Q3 2023 Earnings Call Transcript
- Edwards Lifesciences slips as Wolfe downgrades on emerging rivalry
- Edwards Lifesciences Non-GAAP EPS of $0.59 in-line, revenue of $1.48B in-line
For further details see:
Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback